We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Benchmark Holdings Plc | LSE:BMK | London | Ordinary Share | GB00BGHPT808 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -0.11% | 44.10 | 44.10 | 46.90 | 44.10 | 44.10 | 44.10 | 178,035 | 11:26:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 169.74M | -23.15M | -0.0313 | -14.11 | 326.42M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/2/2018 14:34 | Until now...... Still watching, or is that watching, and still? No hurry to buy for sure. | napoleon 14th | |
09/2/2018 18:22 | This has held up not bad considering the market sell off | john09 | |
31/1/2018 09:04 | After FY results, full ED research note out today reaffirming fair value and business potential. Free access to note here: And 20 mins interview post results with CEO & CFO here: | edmonda | |
29/1/2018 16:34 | Keeping an eye on this; 64p could be a good support level to buy, as in two year chart above. BKY's fundies don't look bad at all, product-wise, but show us the money! | bone apart | |
29/1/2018 08:55 | Yes sorry should have said I sold last week to take up positions elsewhere in some beaten up stocks where i think the upside and liquidity a little better. GLA holders | john09 | |
29/1/2018 08:29 | BMK not having a good run at the moment. Thinking of sellin and protecting my now modest profits. Thoughts on this? Or stick with it as it for now? | btfd497 | |
23/1/2018 18:03 | I thought their strengths and weaknesses was a bit lame too in that broker note | john09 | |
23/1/2018 17:51 | Thanks John - problem with this note is that the worth of this Company is definitely not encapsulated within the prospective 2018 numbers (already nearly half over) but the years beyond, and hence it's rather disappointing not to see them forecasting out a few more years to when the Firm actually makes some profits! Alsio think that 'speculative buy' is a bit of a nonsense rating. All small and mid cap stocks are 'speculative'! | ilovefrogs | |
23/1/2018 17:24 | hxxps://www.beaufort | john09 | |
23/1/2018 17:14 | 800,000 shares traded closed at 69.5p | john09 | |
23/1/2018 11:26 | Yes on the day the price is fine, it’s rather the drop from 80p in the previous session that is a bit frustrating | john09 | |
23/1/2018 11:22 | Market makers dropped price early on to shake out a few. Decent update and the company all set for good future growth with some excellent products. Looking good for further rise and always the chance of a bid from a bigger player. | esther1975 | |
23/1/2018 09:47 | 69p mid, and the presentation to the Analysts is currently happening . The fall from 80p obviously a shame short term | john09 | |
23/1/2018 09:16 | Glad we are bouncing tho! | john09 | |
23/1/2018 09:11 | Uh tried buying more and couldn’t Was too busy unloading my PETS at £1.97 using DMA | john09 | |
23/1/2018 09:00 | Little top up this morning although couldn't get them at the low point. 200dma at 63 provides support. | essential | |
23/1/2018 08:37 | Yep tried to buy not filled | john09 | |
23/1/2018 08:23 | Great price to buy more thanks Mr market | esther1975 | |
23/1/2018 07:25 | Full of confidence going into the new financial year, which bearing in mind 4 months in now they must be happy. Strong position to drive broth for many years to come. This will be acquired soon I think. PE | john09 | |
23/1/2018 07:23 | "2017 has been a year of significant operational and strategic progress for Benchmark Holdings. Despite certain challenges, we have continued our focussed investment in the development of the Group's pipeline and have put in place important technological, infrastructure and organisational building blocks. Benchmark is now one of the leading global providers of advanced nutrition, genetics and animal health in the industry. "The organic growth delivered in the year and the achievement of significant milestones, together with the increased activity in many of our key markets at the end of the year leaves us full of confidence going into the new financial year. The continued growing global demand for aquaculture products, the disease challenges faced, and pressure to limit the use of antibiotics, puts the group in a strong position to drive growth for many years to come." | john09 | |
22/1/2018 21:22 | Tomorrow’s results are the year ended end September so there’s been nearly 4 months of the current year already under the belt too. Hopefully we will get a trading ahead statement tomorrow. It’s the current trading and outlook that’s not priced in. The results to end September are already known | john09 | |
22/1/2018 17:22 | How are your Footasylum you loser | john09 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions